Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Waterhouse

Showing results (251-260 of 358) with videos related to

Pageof 36
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trialDavid R Spigel, Peter M Townley, David M Waterhouse, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research ConsortiumDavid R Spigel, John D Hainsworth, Dianna L Shipley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter studyD A Richards, K A Boehm, D M Waterhouse, et al.
QJM : Monthly Journal of the Association of Physicians|February 10, 2017
Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronismM J Hannon, W C Sze, R Carpenter, et al.
Biological Reviews of the Cambridge Philosophical Society|July 23, 2024
The moulting arthropod: a complete genetic toolkit reviewGiulia Campli, Olga Volovych, Kenneth Kim, et al.
Clinical Genitourinary Cancer|February 15, 2008
Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trialJohn D Hainsworth, David R Spigel, Jeffrey A Sosman, et al.
Nature|September 13, 2023
Uncovering new families and folds in the natural protein universeJanani Durairaj, Andrew M Waterhouse, Toomas Mets, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancerKathy D Miller, Thomas J Saphner, David M Waterhouse, et al.
The New Phytologist|June 12, 2024
Evidence for within-species transition between drought response strategies in Nicotiana benthamianaLeila Asadyar, Felipe Fenselau de Felippes, Julia Bally, et al.
Proceedings. Biological Sciences|March 9, 2022
Long-distance dispersal of pigeons and doves generated new ecological opportunities for host-switching and adaptive radiation by their parasitesBret M Boyd, Nam-Phuong Nguyen, Julie M Allen, et al.
Pageof 36

Showing results (251-260 of 358) with videos related to

Sort By:
Pageof 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trialDavid R Spigel, Peter M Townley, David M Waterhouse, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research ConsortiumDavid R Spigel, John D Hainsworth, Dianna L Shipley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter studyD A Richards, K A Boehm, D M Waterhouse, et al.
QJM : Monthly Journal of the Association of Physicians|February 10, 2017
Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronismM J Hannon, W C Sze, R Carpenter, et al.
Biological Reviews of the Cambridge Philosophical Society|July 23, 2024
The moulting arthropod: a complete genetic toolkit reviewGiulia Campli, Olga Volovych, Kenneth Kim, et al.
Clinical Genitourinary Cancer|February 15, 2008
Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trialJohn D Hainsworth, David R Spigel, Jeffrey A Sosman, et al.
Nature|September 13, 2023
Uncovering new families and folds in the natural protein universeJanani Durairaj, Andrew M Waterhouse, Toomas Mets, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancerKathy D Miller, Thomas J Saphner, David M Waterhouse, et al.
The New Phytologist|June 12, 2024
Evidence for within-species transition between drought response strategies in Nicotiana benthamianaLeila Asadyar, Felipe Fenselau de Felippes, Julia Bally, et al.
Proceedings. Biological Sciences|March 9, 2022
Long-distance dispersal of pigeons and doves generated new ecological opportunities for host-switching and adaptive radiation by their parasitesBret M Boyd, Nam-Phuong Nguyen, Julie M Allen, et al.
Pageof 36